London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Forget anything else, books trading dynamics, focus on the real key news.
Dodge COX Income fund is the major holder. The Income fund as 4% holding in GSK for Income/Dividends
Prior to the 30 December holding Dodge COX Holdings in GlaxoSmithKline on September 30th 2020 under SEC Filings was 41,528,300.
December 31 2020 SEC filings for quarter ending 30/12/2020 under 13 F HR Filing showed Dodge Cox held 62,935,758 GSK shares under ADR February 19 Filing shows Dodge Cox have 154,086,234 ADR's by a further 60%
Of course the above makes a complete mockery of Credit Suisse take down of GSK .
Dodge Cox look for GSK to provide the dividend for “minimum period of 15 months” hence the increase, due to the dividend remaining in place for Financial year 2021.
I suppose Dodge Cox have been hoodwinked and the dividend as no value , the clowns that spout complete BS about Dividend and constantly berate GSK Dividend policy should look and see, or are Dodge Cox just blind, they sure don’t take notice of Credit Suisse and their ILK
One other thing, SEC 13F HR Filings don’t lie or mislead like the brokers do and the City
I posted about this on the 17th
https://www.lse.co.uk/ShareChat.asp?ShareTicker=GSK&share=Glaxosmithkline&page=6&thread=42031C0D-58FC-434B-A462-BB499A970FF7
They note in their end of year reporting the underperformance of Pharma but still loaded up.
If GSK has a kicking in this February and from March and into Spring thing move forward...then so be it...
Get the kicking out of the way inside one month will be better than dragging it out over 2 months or more...
And...if the kicking sharpens the BOD and their focus...4 months down the line ...we could all be better for it...
I would be very, very surprised if GSK traded much lower, meaning sub 11.50.
Barring something left field.
AZN is trading on 20x FY 2021, that's based on converting their EPS
back in the £ from USD, on current FX rates.
That falls below 17X for FY22 very approx, again on current FX conversion
and current consensus.
1.42 on cable is the max I expected, which it hit about in the early hrs.
Some are now mentioning 1.50, not sure I see that but never say never etc.
Fats
“Some are now mentioning 1.50, not sure I see that but never say never etc.”
The £ has become the in vogue currency. Most FX is technical driven. Even though the fundamentals don’t support a stronger pound the algos will drive it up because it’s been singled out by traders. It’s that mass collusion factor again - so dominant in markets.
I want to take full advantage of an overvalued £ so I’ve been hedging other currencies as it rises.
I think $1.50 is almost certain. If it reaches that level any rise above will meet stiff resistance.
I think the Dollar is being shorted quite heavily...if those positions reverse..there could be a snap back
I would guess the size of the forthcoming stimulus will have an affect on that decision..
The inflation story is pushing the markets higher and higher...to the point where people are believing their Dollars are about to turn to sand or such like...
Inflation. Figures been massaged in UK for last 5 years, and with Unemployment at close to 3 million and rising to 5 million by September its going to hit share prices hard, but not Pharma.
Furloughed workers will be unemployed soon and the false economy of the UK will show through. Hard to believe the UK as racked up over a £ 1 trillion in debt inside 10 months.
US Stimulus is priced into the dollar I would say and can expect a snap back, I think Biden will dump some of the of the USA Oil Reserves into the market and that will have an impact on Oil prices, that are at stupid levels due to the OPEC Russian cartel .
UK House prices are heading for a crash on scale of 1990's , but the UK Chancellor fueled the Housing price stupidity and his give away tax breaks are one of the worst I can recall in the last 50 years.
Apart from that, expect NHS Staff to strike, as they are getting no pay rises, and there £500 bonus , is actaully only given them £325.00 while the UK Chancellor as been paying people to do nothing on Furlough, Its leaving a bitter taste in NHS Staff mouths now...
Shingrix which was deemed one of GSK's best selling products was taking a hit due to the Pandemic as he had to be administered face to face by GP Surgery's, Health Centres etc, now that there is a roadmap to reopening, this should help the SP push up over the next 6 months. I have been very surprised the SP has been floundering at these levels, GSK seem to have been targeted by the market for not having a Covid Vaccine, but I think they are done very well to wait it out and come up with one that can also fight against the new Variants as well. DYOR but in my opinion this is a £17+ share, here is hoping that it get's back to these levels again. Long term hold for me. Divi is the Cherry on top.
Agree stamp duty holiday only help those who can afford to buy. Waste of government money. Unemployed can't get a mortgage
Irontaz.
GSK did not get much FDA cash, the bulk went to Sanofi, the UK as not given GSK anything of substance.
The Vaccine myth with GSK is one that makes me wonder who does the reporting.
We are yet to seethe Medicago Vaccine news, which Canada is counting on.
GSK with CVAC as never been reported, the current vaccine in phase 3 trails will earn GSK capital on the 10% equity stake and 300 million doese ready to go, the data to the EU as been filed as they went along, so it would not take much to approve it and at 10.80 Euros per shot, is a lot of capital.
The NHS would bring the country to its knees if you gave them everything they asked for.
This share is going to fly So undervalued end today in the £12,20s no question
Quiet funny that. NHS staff did not ask for anything, but now they lost there annual pay rise, which is next to nothing.
Funny how the UK Abuses the NHS workers, they want them to work through a pandemic, not allowed there holidays, and 3 million people get paid on Furlough for doing nothing. Worse your Idiotic Chancellor gives away taxes on stamp duty to people who dont need it , and then says no money for the people who saved lives, the lesson here is simple, NHS staff take there holidays, work to contracted hours only an